• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Momenta Pharmaceuticals Inc

+ Add to Watchlist


11.2500 USD 0.2700 2.34%

As of 20:10:00 ET on 09/22/2014.

Snapshot for Momenta Pharmaceuticals Inc (MNTA)

Open: 11.4900 Day's Range: 11.0400 - 11.7100 Volume: 404,405
Previous Close: 11.5200 52wk Range: 9.8500 - 19.9000 1-Yr Rtn: -23.57%

Stock Chart for MNTA

No chart data available.
  • MNTA:US 11.2500
  • 1D
  • 1M
  • 1Y
Interactive MNTA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MNTA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -2.1300
Est. EPS (USD) (12/2014) -1.0810
Est. PEG Ratio -
Market Cap (M USD) 594.15
Shares Outstanding (M) 52.81
30 Day Average Volume 326,202
Price/Book (mrq) 2.6332
Price/Sale (ttm) 12.7487
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MNTA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MNTA

Momenta Pharmaceuticals, Inc. is a biotechnology company. The Company specializes in sequencing and engineering of complex sugars for the development of improved versions of existing drugs, the development of novel drugs, and the discovery of new biological processes. Momenta also develops technology-enabled generic products.

Craig A WheelerPresident/CEOMichael FrankenPres:Biosimilars Business/Senior VP
Richard P Shea "Rick"Senior VP/CFOBruce A LeicherSenior VP/Secy/General Cnsl
More Company Profile & Key Executives for MNTA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil